NEWSROOM

Insights, events, and firm news for life sciences, pharmaceutical, chemical, and technology innovators.

AI-GENERATED PRIOR ART IN PATENT LAW: HIDDEN RISKS YOU CAN’T IGNORE

AI can accelerate innovation, but it can also introduce synthetic prior art that undermines biotech IP. Explore key risks in operability, public access, and misuse. Learn how to protect your patent filings with expert strategies.

Read More